# Nuclide record astatine-211-alpha-therapy (technology). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/technologies/astatine-211-alpha-therapy/>
  a schema:MedicalTherapy ;
  nuclide:kind "technology" ;
  schema:identifier "astatine-211-alpha-therapy" ;
  schema:name "Astatine-211 alpha therapy"@en ;
  schema:description "A rare alpha-emitting halogen that can be attached to antibodies and small molecules like iodine, tested in leukaemia conditioning and brain and ovarian cancer."@en ;
  schema:url <https://nuclide.cc/technologies/astatine-211-alpha-therapy/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Astatine> ;
  schema:citation <https://en.wikipedia.org/wiki/Astatine> ;
  nuclide:status "phase-1" ;
  nuclide:related <https://nuclide.cc/isotopes/at-211/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/targeted-alpha-therapy/>, <https://nuclide.cc/technologies/radioligand-therapy/> ;
  nuclide:dependsOn <https://nuclide.cc/technologies/targeted-alpha-therapy/>, <https://nuclide.cc/technologies/medical-cyclotrons-synthesis-modules/> .